The concentration of the conventional biomarkers (CA125, CA 19.9, and CEA) and signal-to-background ratio of the EVs assay were used for classifying the healthy, benign, early-, and late-stage CRC samples. This evidence concerns the gene MUC16 and colorectal carcinoma.